RO102379A2 - Procedeu de izolare a alfa2-macroglobulinei alfa2 m, umane, de inalta puritate - Google Patents
Procedeu de izolare a alfa2-macroglobulinei alfa2 m, umane, de inalta puritateInfo
- Publication number
- RO102379A2 RO102379A2 RO1988137153A RO13715388A RO102379A2 RO 102379 A2 RO102379 A2 RO 102379A2 RO 1988137153 A RO1988137153 A RO 1988137153A RO 13715388 A RO13715388 A RO 13715388A RO 102379 A2 RO102379 A2 RO 102379A2
- Authority
- RO
- Romania
- Prior art keywords
- alpha
- centrifuging
- gel
- sodium
- serum
- Prior art date
Links
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 title 1
- 101710187168 Alpha-2-macroglobulin Proteins 0.000 title 1
- 101710136034 Alpha-2-macroglobulin homolog Proteins 0.000 title 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 2
- 101000799972 Homo sapiens Alpha-2-macroglobulin Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010033645 Pancreatitis Diseases 0.000 abstract 1
- 206010033647 Pancreatitis acute Diseases 0.000 abstract 1
- 201000003229 acute pancreatitis Diseases 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 230000006020 chronic inflammation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003527 fibrinolytic agent Substances 0.000 abstract 1
- 230000003480 fibrinolytic effect Effects 0.000 abstract 1
- 238000002523 gelfiltration Methods 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 102000049437 human A2M Human genes 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO137153A RO102379B1 (ro) | 1988-12-28 | 1988-12-28 | PROCEDEU DE IZOLARE A ALFA 2-MACROGLOBULINEI ALFA 2 M, UMANE, DE îNALTA PURITATE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO137153A RO102379B1 (ro) | 1988-12-28 | 1988-12-28 | PROCEDEU DE IZOLARE A ALFA 2-MACROGLOBULINEI ALFA 2 M, UMANE, DE îNALTA PURITATE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RO102379A2 true RO102379A2 (ro) | 1991-10-30 |
| RO102379B1 RO102379B1 (ro) | 1991-10-31 |
Family
ID=20123451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RO137153A RO102379B1 (ro) | 1988-12-28 | 1988-12-28 | PROCEDEU DE IZOLARE A ALFA 2-MACROGLOBULINEI ALFA 2 M, UMANE, DE îNALTA PURITATE |
Country Status (1)
| Country | Link |
|---|---|
| RO (1) | RO102379B1 (ro) |
-
1988
- 1988-12-28 RO RO137153A patent/RO102379B1/ro unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO102379B1 (ro) | 1991-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI971058A0 (fi) | Menetelmä sakkaroosipitoisten liuosten fraktioimiseksi | |
| AU7307998A (en) | Transegenic production of antibodies in milk | |
| IE36670L (en) | Recovery of antithrombin | |
| HU218463B (hu) | Eljárás terápiás célra használható immunglobulin G koncentrátum előállítására | |
| Bose et al. | Role of the carbohydrate moiety in determining the survival of interferon in the circulation | |
| FR2672604B1 (fr) | Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue. | |
| JPH04502907A (ja) | 抗トロンビン | |
| FI953565A7 (fi) | Uusi antikoagulanttikofaktoriaktiivisuus | |
| Ryan et al. | Characterization and purification of mouse macrophage procoagulant-inducing factor. | |
| US4806346A (en) | Method for isolation of antigen specific immunoglobulin | |
| US4264589A (en) | Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system | |
| US4178285A (en) | Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system | |
| RO102379A2 (ro) | Procedeu de izolare a alfa2-macroglobulinei alfa2 m, umane, de inalta puritate | |
| EP0551084A2 (en) | Human antithrombin-III preparation | |
| FR2610633B1 (fr) | Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament | |
| EP0253331B1 (en) | Thrombin-binding substance and process for its preparation | |
| Williams et al. | Purification and properties of a procoagulant from peninsula tiger snake (Notechis ater niger) venom | |
| WO1983001899A1 (en) | Process for the production of human gamma-interferon | |
| DE3751605D1 (de) | Therapeutisches Blutprodukt, Mittel und Verfahren zu dessen Erzeugung. | |
| Nathoo et al. | Purification and properties of two different α1-protease inhibitors from mouse plasma | |
| US5324628A (en) | Use of chymotrypsin for the inactivation of prekallikrein activator | |
| WO1991015582A3 (en) | Purified rap gaps, rap gap sequences, and uses thereof | |
| SU698623A1 (ru) | Способ получени ингибитора трипсина | |
| SU962302A1 (ru) | Способ одновременной очистки протеолитического фермента и его обратимого ингибитора | |
| Tsutsumi et al. | Purification of messenger RNA coding for rat liver aldolase B subunit |